• SPX
  • $5,949.17
  • -0.61 %
  • -$36.21
  • DJI
  • $43,750.86
  • -0.47 %
  • -$207.33
  • N225
  • $38,878.54
  • 0.89 %
  • $342.84
  • FTSE
  • $8,071.19
  • 0.51 %
  • $40.86
  • IXIC
  • $19,107.65
  • -0.64 %
  • -$123.07
Lexicon Pharmaceuticals, Inc. (LXRX) Latest News

Lexicon Pharmaceuticals, Inc. (LXRX) Latest News

NASDAQ Currency in USD Disclaimer

Stock Price

$1.06

-$0.04

(-3.21%)

Day's range
$1.05
Day's range
$1.08

Latest News of LXRX

Lexicon Pharmaceuticals, Inc. (LXRX): The Best Multibagger Penny Stock of 2025?

By Yahoo! Finance | 2 months ago

An article lists the top multibagger penny stocks of 2025, including Lexicon Pharmaceuticals, analyzing its potential. Multibagger stocks can yield significant returns but are risky. Market trends sug...

Lexicon Pharmaceuticals (NASDAQ:LXRX) adds US$51m to market cap in the past 7 days, though investors from five years ago are still down 69%

By Yahoo! Finance | 5 months ago

Long term investing can be profitable, but not always immune to losses. For instance, Lexicon Pharmaceuticals' stock has declined significantly over five years, indicating high risk due to low revenue...

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.